It would be nice if the EU would eliminate the old (“mutual recognition”) pathway for approval of small-molecule drugs, but it probably won’t happen anytime soon.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”